Skip to main content

Table 2 Treatment-related toxicities of all 19 patients enrolled.

From: Phase II trial of weekly 24-hour infusion of gemcitabine in patients with advanced gallbladder and biliary tract carcinoma

 

Number of patients (%)

NCI-CTC Grade

1

2

3

4

Leukopenia

2 (11)

6 (32)

3 (16)

0

Neutropenia

3 (16)

1 (5)

2 (11)

2 (11)

Anemia

0

1 (5)

0

0

Thrombocytopenia

3 (16)

3 (16)

0

1 (5)

Diarrhea

1 (5)

1 (5)

0

0

Nausea/emesis

5 (26)

2 (11)

0

0

Stomatitis

3 (16)

2 (11)

1 (5)

0

  1. NCI-CTC: National Cancer Institute Common Toxicity Criteria